Matches in SemOpenAlex for { <https://semopenalex.org/work/W1604133079> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W1604133079 abstract "Introduction: Nonsustained VT (NSVT) detected by Holter (Holter +NSVT) is a major risk factor (RF) for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM). We hypothesized that using a higher heart rate cut-off and prolonged monitoring for detecting NSVT would improve its accuracy in predicting sustained ventricular arrhythmias (VA). Methods: We prospectively enrolled 56 patients (mean 44±14 yrs) with HCM, who had a preexisting prophylactic ICD. We assessed the prevalence of rapid NSVT (+RNSVT, ≥4 beats at 167-200 bpm) detected by their ICD within the first 12 months of implant. The primary outcome was appropriate ICD therapy after implant. Results: The prevalence of RF at ICD implant was 50% for syncope, 57% for Holter +NSVT, 45% for +family history SCD, and 25% for septum ≥ 30mm. The prevalence of 0, 1, 2 and ≥3 RF was 2, 32, 54 and 13%, respectively. +RNSVT occurred in 19 patients (34%) of whom 4 were Holter -NSVT. When compared to -RNSVT, those with +RNSVT had less syncope (21 vs 65%, p=0.004) but more Holter +NSVT (79 vs 46%, p=0.02). Over a median follow-up of 59 (25, 123) months after ICD implant, 8 patients had ≥1 appropriate ICD therapy from VA. According to the number of RF, the proportion of patients with VA was 0=0%, 1=6%, 2=13%, ≥3=43% (p=0.11). +RNSVT was associated with higher VA compared to Holter +NSVT (Figure 1A). +RNSVT predicted VA by Cox regression analysis, both univariate [odds ratio 10, 95% CI 1-84, p=0.03] and adjusted for differences in RF [adjusted odds ratio 11, 95% CI 1-114, p=0.046]. ROC analysis for +RNSVT (area under curve 0.78, p=0.02) showed the optimal cut-point to be RNSVT ≥2 episodes (Figure 1B) for discriminating patients with and without VA (Sensitivity 71%, Specificity 83%, PPV 38%, NPV 95%). Conclusions: RNSVT detected from continuous device monitoring is an independent predictor of VA in HCM patients and a better risk stratifier than Holter +NSVT. The role of implantable loop monitoring to detect RNSVT and evaluate VA risk in HCM warrants study" @default.
- W1604133079 created "2016-06-24" @default.
- W1604133079 creator A5028591599 @default.
- W1604133079 creator A5030428751 @default.
- W1604133079 creator A5040760200 @default.
- W1604133079 creator A5042688574 @default.
- W1604133079 creator A5047179300 @default.
- W1604133079 creator A5076390550 @default.
- W1604133079 creator A5088641103 @default.
- W1604133079 creator A5090651414 @default.
- W1604133079 creator A5090951642 @default.
- W1604133079 date "2014-11-25" @default.
- W1604133079 modified "2023-09-25" @default.
- W1604133079 title "Abstract 12969: Rapid Nonsustained Ventricular Tachycardia Detected by Continuous Device Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy: Redefining a Traditional Risk Marker" @default.
- W1604133079 doi "https://doi.org/10.1161/circ.130.suppl_2.12969" @default.
- W1604133079 hasPublicationYear "2014" @default.
- W1604133079 type Work @default.
- W1604133079 sameAs 1604133079 @default.
- W1604133079 citedByCount "0" @default.
- W1604133079 crossrefType "journal-article" @default.
- W1604133079 hasAuthorship W1604133079A5028591599 @default.
- W1604133079 hasAuthorship W1604133079A5030428751 @default.
- W1604133079 hasAuthorship W1604133079A5040760200 @default.
- W1604133079 hasAuthorship W1604133079A5042688574 @default.
- W1604133079 hasAuthorship W1604133079A5047179300 @default.
- W1604133079 hasAuthorship W1604133079A5076390550 @default.
- W1604133079 hasAuthorship W1604133079A5088641103 @default.
- W1604133079 hasAuthorship W1604133079A5090651414 @default.
- W1604133079 hasAuthorship W1604133079A5090951642 @default.
- W1604133079 hasConcept C126322002 @default.
- W1604133079 hasConcept C141071460 @default.
- W1604133079 hasConcept C156957248 @default.
- W1604133079 hasConcept C164705383 @default.
- W1604133079 hasConcept C2775935837 @default.
- W1604133079 hasConcept C2776331378 @default.
- W1604133079 hasConcept C2777093960 @default.
- W1604133079 hasConcept C2778198053 @default.
- W1604133079 hasConcept C2778797674 @default.
- W1604133079 hasConcept C2780185194 @default.
- W1604133079 hasConcept C2781411149 @default.
- W1604133079 hasConcept C50440223 @default.
- W1604133079 hasConcept C71924100 @default.
- W1604133079 hasConceptScore W1604133079C126322002 @default.
- W1604133079 hasConceptScore W1604133079C141071460 @default.
- W1604133079 hasConceptScore W1604133079C156957248 @default.
- W1604133079 hasConceptScore W1604133079C164705383 @default.
- W1604133079 hasConceptScore W1604133079C2775935837 @default.
- W1604133079 hasConceptScore W1604133079C2776331378 @default.
- W1604133079 hasConceptScore W1604133079C2777093960 @default.
- W1604133079 hasConceptScore W1604133079C2778198053 @default.
- W1604133079 hasConceptScore W1604133079C2778797674 @default.
- W1604133079 hasConceptScore W1604133079C2780185194 @default.
- W1604133079 hasConceptScore W1604133079C2781411149 @default.
- W1604133079 hasConceptScore W1604133079C50440223 @default.
- W1604133079 hasConceptScore W1604133079C71924100 @default.
- W1604133079 hasIssue "suppl_2" @default.
- W1604133079 hasLocation W16041330791 @default.
- W1604133079 hasOpenAccess W1604133079 @default.
- W1604133079 hasPrimaryLocation W16041330791 @default.
- W1604133079 hasRelatedWork W2042010291 @default.
- W1604133079 hasRelatedWork W2134741931 @default.
- W1604133079 hasRelatedWork W2163200510 @default.
- W1604133079 hasRelatedWork W2618889545 @default.
- W1604133079 hasRelatedWork W2919365189 @default.
- W1604133079 hasRelatedWork W2981657997 @default.
- W1604133079 hasRelatedWork W3084242616 @default.
- W1604133079 hasRelatedWork W3185673077 @default.
- W1604133079 hasRelatedWork W4220959329 @default.
- W1604133079 hasRelatedWork W4241358163 @default.
- W1604133079 hasVolume "130" @default.
- W1604133079 isParatext "false" @default.
- W1604133079 isRetracted "false" @default.
- W1604133079 magId "1604133079" @default.
- W1604133079 workType "article" @default.